Đang chuẩn bị liên kết để tải về tài liệu:
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Post-surgical prognosis is usually poor for combined hepatocellular cholangiocarcinoma (CHCC-CC), a rare primary liver cancer. Although midkine (MK) is a prognostic biomarker for several known cancers, it is not known whether it can be used as such in resectable CHCC-CC. | Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

TÀI LIỆU LIÊN QUAN

Clinical significance of BCL2, C-MYC, and BCL6 genetic abnormalities, epstein barr virus infection, CD5 protein expression, germinal center B cell non germinal center B cell subtypes, Co-expression of MYC/BCL2 proteins and Co-expression of MYC/BCL2/BCL6 proteins in diffuse large B-cell lymphoma: A clinical and pathological correlation study of 120 patients

The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients

Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression

Enhancing the efficiency of the Pichia pastoris AOX1 promoter via the synthetic positive feedback circuit of transcription factor Mxr1

Aberrant expression of ALK and EZH2 in Merkel cell carcinoma

Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study

Expression pattern of CDK12 protein in gastric cancer and its positive correlation with CD8+ cell density and CCL12 expression

Expression and clinical significance of PDL1 and BRAF expression in nasopharyngeal carcinoma

Báo cáo y học: "A consensus prognostic gene expression classifier for ER positive breast cancer"